Induced appearance of adenylate-deaminating activity in highly purified bovine liver mitochondrial monoamine oxidase.
D000227:Adenine Nucleotides; D000244:Adenosine Diphosphate; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D000619:Aminohydrolases / Q000037:antagonists & inhibitors; D000818:Animals; D002417:Cattle; D003641:Deamination; D004872:Ergocalciferols / Q000009:adverse effects; D005033:Ethylmaleimide / Q000494:pharmacology; D006898:Hydroxylamines / Q000494:pharmacology; D007292:Inosine Nucleotides; D007538:Isoniazid / Q000494:pharmacology; D050356:Lipid Metabolism; D008297:Male; D008930:Mitochondria, Liver / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009829:Oleic Acids / Q000494:pharmacology; D010084:Oxidation-Reduction; D010545:Peroxides / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D013438:Sulfhydryl Compounds / Q000032:analysis
D000227:Adenine Nucleotides; D004872:Ergocalciferols; D006898:Hydroxylamines; D007292:Inosine Nucleotides; D008996:Monoamine Oxidase Inhibitors; D009829:Oleic Acids; D010545:Peroxides; D013438:Sulfhydryl Compounds; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D008995:Monoamine Oxidase; D000619:Aminohydrolases; D005033:Ethylmaleimide; D007538:Isoniazid